No Data
No Data
Mural Oncology Grants Stock Options and Restricted Stock Units to New Employees as Part of 2024 Inducement Plan
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
12 Health Care Stocks Moving In Monday's Pre-Market Session
Mural Oncology Reports Positive ARTISTRY-1 Trial Results for Nemvaleukin in Advanced Solid Tumors, Including Platinum-Resistant Ovarian Cancer
Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in Its ARTISTRY-1 Clinical Trial of Nemvaleukin, Its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer